Skip to main content
Top
Published in: Endocrine 2/2011

01-10-2011 | Original Article

Epicardial adipose tissue thickness in type 1 diabetic patients

Authors: Dilek Yazıcı, Beste Özben, Dilek Yavuz, Oğuzhan Deyneli, Hasan Aydın, Özlem Tarcin, Sema Akalın

Published in: Endocrine | Issue 2/2011

Login to get access

Abstract

Insulin resistance is getting important in the course of type 1 diabetes mellitus. Visceral fat depot is associated with insulin resistance and assessment of epicardial fat thickness is a way of measuring visceral fat. The aim of the study was to measure epicardial adipose tissue (EAT) thickness and to determine its relationship with waist-hip-ratio (WHR) and estimated glucose disposal rate (eGDR) in adult type 1 diabetic patients. Thirty-six type 1 diabetic patients (aged 31 ± 8 years; Female/Male: 22/14) and 43 age, gender and BMI matched healthy controls were included. Fasting blood glucose (FBG), hemoglobin A1c, and lipid profiles were measured. Waist-hip-ratio (WHR) was calculated. Daily insulin dose/kg of patients were recorded and eGDR of all subjects was calculated. Epicardial adipose tissue (EAT) thickness was evaluated by echocardiography. EAT thickness of the type 1 diabetic patients was significantly higher than controls (3.30 ± 1.06 vs. 2.30 ± 0.34 mm, P < 0.0001). EAT thickness was correlated with age (P = 0.05; r = 0.35), WHR (P = 0.003; r = 0.67), daily insulin dose/kg (r = 0.45, P = 0.005), and eGDR (r = −0.55, P = 0.0004). Multivariate analysis revealed WHR and eGDR to be related to EAT among age, WHR, daily insulin dose/kg, eGDR, FBG, and hemoglobin A1c (r2 of the model = 0.64). Epicardial adipose tissue thickness is increased in type 1 diabetic patients compared to controls and is related to WHR and eGDR in this group of patients. This measurement may point to the presence of insulin resistance in type 1 diabetic patients.
Literature
1.
go back to reference S.S. Soedamah-Muthu, J.H. Fuller, H.E. Mulnier, V.S. Raleigh, R.A. Lawrenson, H.M. Colhoun, All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49, 660–666 (2006)PubMedCrossRef S.S. Soedamah-Muthu, J.H. Fuller, H.E. Mulnier, V.S. Raleigh, R.A. Lawrenson, H.M. Colhoun, All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49, 660–666 (2006)PubMedCrossRef
2.
go back to reference G. Pambianco, T. Costacou, D. Ellis, D.J. Becker, R. Klein, T.J. Orchard, The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55, 1463–1469 (2006)PubMedCrossRef G. Pambianco, T. Costacou, D. Ellis, D.J. Becker, R. Klein, T.J. Orchard, The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55, 1463–1469 (2006)PubMedCrossRef
3.
go back to reference E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, V. Cacciatori, L. Santi, G. Targher, R. Bonadonna, M. Muggeo, HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25, 1135–1141 (2002)PubMedCrossRef E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, V. Cacciatori, L. Santi, G. Targher, R. Bonadonna, M. Muggeo, HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25, 1135–1141 (2002)PubMedCrossRef
4.
go back to reference A.J. Hanley, K. Williams, M.P. Stern, S.M. Haffner, Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25, 1177–1184 (2002)PubMedCrossRef A.J. Hanley, K. Williams, M.P. Stern, S.M. Haffner, Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25, 1177–1184 (2002)PubMedCrossRef
5.
go back to reference E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the DiabetesControl and Complications Trial. Diabetes Care 30, 707–712 (2007)PubMedCrossRef E.S. Kilpatrick, A.S. Rigby, S.L. Atkin, Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the DiabetesControl and Complications Trial. Diabetes Care 30, 707–712 (2007)PubMedCrossRef
6.
go back to reference T.J. Orchard, J.C. Olson, J.R. Erbey, K. Williams, K.Y. Forrest, L. Smithline Kinder, D. Ellis, D.J. Becker, Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26, 1374–1379 (2003)PubMedCrossRef T.J. Orchard, J.C. Olson, J.R. Erbey, K. Williams, K.Y. Forrest, L. Smithline Kinder, D. Ellis, D.J. Becker, Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26, 1374–1379 (2003)PubMedCrossRef
7.
go back to reference S.S. Soedamah-Muthu, N. Chaturvedi, M. Toeller, B. Ferriss, P. Reboldi, G. Michel, C. Manes, J.H. Fuller, EURODIAB Prospective Complications Study Group: risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27, 530–537 (2004)PubMedCrossRef S.S. Soedamah-Muthu, N. Chaturvedi, M. Toeller, B. Ferriss, P. Reboldi, G. Michel, C. Manes, J.H. Fuller, EURODIAB Prospective Complications Study Group: risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27, 530–537 (2004)PubMedCrossRef
8.
go back to reference M. McGill, L. Molyneaux, S.M. Twigg, D.K. Yue, The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J. Diabetes Complicat. 22, 18–23 (2008)PubMedCrossRef M. McGill, L. Molyneaux, S.M. Twigg, D.K. Yue, The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J. Diabetes Complicat. 22, 18–23 (2008)PubMedCrossRef
9.
go back to reference K.M. Rexrode, J.E. Buring, J.E. Manson, Abdominal and total adiposity and risk of coronary heart disease in men. Int. J. Obes. Relat. Metab. Disord. 25, 1047–1056 (2001)PubMedCrossRef K.M. Rexrode, J.E. Buring, J.E. Manson, Abdominal and total adiposity and risk of coronary heart disease in men. Int. J. Obes. Relat. Metab. Disord. 25, 1047–1056 (2001)PubMedCrossRef
10.
go back to reference K.M. Rexrode, V.J. Carey, C.H. Hennekens, E.E. Walters, G.A. Colditz, M.J. Stampfer, W.C. Willett, J.E. Manson, Abdominal adiposity and coronary heart disease in women. JAMA 280, 1843–1848 (1998)PubMedCrossRef K.M. Rexrode, V.J. Carey, C.H. Hennekens, E.E. Walters, G.A. Colditz, M.J. Stampfer, W.C. Willett, J.E. Manson, Abdominal adiposity and coronary heart disease in women. JAMA 280, 1843–1848 (1998)PubMedCrossRef
11.
go back to reference A.N. Peiris, M.S. Sothmann, R.G. Hoffmann, M.I. Hennes, C.R. Wilson, A.B. Gustafson, A.H. Kissebah, Adiposity, fat distribution, and cardiovascular risk. Ann. Intern. Med. 110, 867–872 (1989)PubMed A.N. Peiris, M.S. Sothmann, R.G. Hoffmann, M.I. Hennes, C.R. Wilson, A.B. Gustafson, A.H. Kissebah, Adiposity, fat distribution, and cardiovascular risk. Ann. Intern. Med. 110, 867–872 (1989)PubMed
12.
go back to reference G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, F. Leonetti, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11, 304–310 (2003)PubMedCrossRef G. Iacobellis, F. Assael, M.C. Ribaudo, A. Zappaterreno, G. Alessi, U. Di Mario, F. Leonetti, Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11, 304–310 (2003)PubMedCrossRef
13.
go back to reference J. Shirani, K. Berezowski, W.C. Roberts, Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am. J. Cardiol. 76, 414–418 (1995)PubMedCrossRef J. Shirani, K. Berezowski, W.C. Roberts, Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am. J. Cardiol. 76, 414–418 (1995)PubMedCrossRef
14.
go back to reference G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163–5168 (2003)PubMedCrossRef G. Iacobellis, M.C. Ribaudo, F. Assael, E. Vecci, C. Tiberti, A. Zappaterreno, U. Di Mario, F. Leonetti, Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88, 5163–5168 (2003)PubMedCrossRef
15.
go back to reference A.E. Malavazos, F. Ermetici, C. Coman, M.M. Corsi, L. Morricone, B. Ambrosi, Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int. J. Cardiol. 121, 132–134 (2007)PubMedCrossRef A.E. Malavazos, F. Ermetici, C. Coman, M.M. Corsi, L. Morricone, B. Ambrosi, Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int. J. Cardiol. 121, 132–134 (2007)PubMedCrossRef
16.
go back to reference G. Iacobellis, F. Leonetti, N. Singh, A.M. Sharma, Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int. J. Cardiol. 115, 272–273 (2007)PubMedCrossRef G. Iacobellis, F. Leonetti, N. Singh, A.M. Sharma, Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int. J. Cardiol. 115, 272–273 (2007)PubMedCrossRef
17.
go back to reference H. Aydin, A. Toprak, O. Deyneli, D. Yazici, O. Tarçin, S. Sancak, D. Yavuz, S. Akalin, Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab. Syndr. Relat. Disord. 8, 229–234 (2010)PubMedCrossRef H. Aydin, A. Toprak, O. Deyneli, D. Yazici, O. Tarçin, S. Sancak, D. Yavuz, S. Akalin, Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab. Syndr. Relat. Disord. 8, 229–234 (2010)PubMedCrossRef
18.
go back to reference R. Taguchi, J. Takasu, Y. Itani, R. Yamamoto, K. Yokoyama, S. Watanabe, Y. Masuda, Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 157, 203–209 (2001)PubMedCrossRef R. Taguchi, J. Takasu, Y. Itani, R. Yamamoto, K. Yokoyama, S. Watanabe, Y. Masuda, Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 157, 203–209 (2001)PubMedCrossRef
19.
go back to reference G. Iacobellis, A.M. Sharma, Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr. Pharm. Des. 13, 2180–2184 (2007)PubMedCrossRef G. Iacobellis, A.M. Sharma, Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr. Pharm. Des. 13, 2180–2184 (2007)PubMedCrossRef
20.
go back to reference A.M. de Vos, M. Prokop, C.J. Roos, M.F. Meijs, Y.T. van der Schouw, A. Rutten, P.M. Gorter, M.J. Cramer, P.A. Doevendans, B.J. Rensing, M.L. Bartelink, B.K. Velthuis, A. Mosterd, M.L. Bots, Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur. Heart J. 29, 777–783 (2008)PubMedCrossRef A.M. de Vos, M. Prokop, C.J. Roos, M.F. Meijs, Y.T. van der Schouw, A. Rutten, P.M. Gorter, M.J. Cramer, P.A. Doevendans, B.J. Rensing, M.L. Bartelink, B.K. Velthuis, A. Mosterd, M.L. Bots, Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur. Heart J. 29, 777–783 (2008)PubMedCrossRef
21.
go back to reference L.M. Thorn, C. Forsblom, J. Fagerudd, M.C. Thomas, K. Pettersson-Fernholm, M. Saraheimo, J. Wadén, M. Rönnback, M. Rosengård-Bärlund, C.G. Björkesten, M.R. Taskinen, P.H. Groop, FinnDiane Study Group: metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28, 2019–2024 (2005)PubMedCrossRef L.M. Thorn, C. Forsblom, J. Fagerudd, M.C. Thomas, K. Pettersson-Fernholm, M. Saraheimo, J. Wadén, M. Rönnback, M. Rosengård-Bärlund, C.G. Björkesten, M.R. Taskinen, P.H. Groop, FinnDiane Study Group: metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28, 2019–2024 (2005)PubMedCrossRef
22.
go back to reference G. Pambianco, T. Costacou, T.J. Orchard, The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30, 1248–1254 (2007)PubMedCrossRef G. Pambianco, T. Costacou, T.J. Orchard, The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes Care 30, 1248–1254 (2007)PubMedCrossRef
23.
go back to reference K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, T.J. Orchard, Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49, 626–632 (2000)PubMedCrossRef K.V. Williams, J.R. Erbey, D. Becker, S. Arslanian, T.J. Orchard, Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49, 626–632 (2000)PubMedCrossRef
24.
go back to reference E. Ho, Y. Shimada, Formation of the epicardium studied with the scanning electron microscope. Dev. Biol. 66, 579–585 (1978)PubMedCrossRef E. Ho, Y. Shimada, Formation of the epicardium studied with the scanning electron microscope. Dev. Biol. 66, 579–585 (1978)PubMedCrossRef
25.
go back to reference J.M. Marchington, C.A. Mattacks, C.M. Pond, Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Biochem. Physiol. B. 94, 225–232 (1989)CrossRef J.M. Marchington, C.A. Mattacks, C.M. Pond, Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Biochem. Physiol. B. 94, 225–232 (1989)CrossRef
26.
go back to reference G. Iacobellis, G. Barbaro, The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm. Metab. Res. 40, 442–445 (2008)PubMedCrossRef G. Iacobellis, G. Barbaro, The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm. Metab. Res. 40, 442–445 (2008)PubMedCrossRef
27.
go back to reference N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, F. Lopez-Jimenez, Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354–359 (2006)PubMedCrossRef N. Chaowalit, V.K. Somers, P.A. Pellikka, C.S. Rihal, F. Lopez-Jimenez, Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 186, 354–359 (2006)PubMedCrossRef
28.
go back to reference R. Djaberi, J.D. Schuijf, J.M. Van Werkhoven, G. Nucifora, J.W. Jukema, J.J. Bax, Relation of epicardial adipose tissue to coronary atherosclerosis. Am. J. Cardiol. 102, 1602–1607 (2008)PubMedCrossRef R. Djaberi, J.D. Schuijf, J.M. Van Werkhoven, G. Nucifora, J.W. Jukema, J.J. Bax, Relation of epicardial adipose tissue to coronary atherosclerosis. Am. J. Cardiol. 102, 1602–1607 (2008)PubMedCrossRef
29.
go back to reference S. Eroglu, L.E. Sade, A. Yildirir, U. Bal, S. Ozbicer, A.S. Ozgul, H. Bozbas, A. Aydinalp, H. Muderrisoglu, Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 19, 211–217 (2009)PubMedCrossRef S. Eroglu, L.E. Sade, A. Yildirir, U. Bal, S. Ozbicer, A.S. Ozgul, H. Bozbas, A. Aydinalp, H. Muderrisoglu, Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 19, 211–217 (2009)PubMedCrossRef
30.
go back to reference C.P. Wang, H.L. Hsu, W.C. Hung, T.H. Yu, Y.H. Chen, C.A. Chiu, L.F. Lu, F.M. Chung, S.J. Shin, Y.J. Lee, Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin. Endocrinol. (Oxf.) 70, 876–882 (2009)CrossRef C.P. Wang, H.L. Hsu, W.C. Hung, T.H. Yu, Y.H. Chen, C.A. Chiu, L.F. Lu, F.M. Chung, S.J. Shin, Y.J. Lee, Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin. Endocrinol. (Oxf.) 70, 876–882 (2009)CrossRef
31.
go back to reference G. Iacobellis, F. Leonetti, Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab. 90, 6300–6302 (2005)PubMedCrossRef G. Iacobellis, F. Leonetti, Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab. 90, 6300–6302 (2005)PubMedCrossRef
32.
go back to reference G. Iacobellis, G. Barbaro, H.C. Gerstein, Relationship of epicardial fat thickness and fasting glucose. Int. J. Cardiol. 128, 424–426 (2008)PubMedCrossRef G. Iacobellis, G. Barbaro, H.C. Gerstein, Relationship of epicardial fat thickness and fasting glucose. Int. J. Cardiol. 128, 424–426 (2008)PubMedCrossRef
33.
go back to reference N. Mattsson, T. Rönnemaa, M. Juonala, J.S. Viikari, O.T. Raitakari, The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J. Intern. Med. 261, 159–169 (2007)PubMedCrossRef N. Mattsson, T. Rönnemaa, M. Juonala, J.S. Viikari, O.T. Raitakari, The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J. Intern. Med. 261, 159–169 (2007)PubMedCrossRef
34.
go back to reference J. Nádas, Z. Putz, J. Fövényi, Z. Gaál, A. Gyimesi, T. Hídvégi, N. Hosszúfalusi, G. Neuwirth, T. Oroszlán, P. Pánczél, G. Széles, G. Vándorfi, G. Winkler, I. Wittmann, G. Jermendy, Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 117, 107–112 (2009)PubMedCrossRef J. Nádas, Z. Putz, J. Fövényi, Z. Gaál, A. Gyimesi, T. Hídvégi, N. Hosszúfalusi, G. Neuwirth, T. Oroszlán, P. Pánczél, G. Széles, G. Vándorfi, G. Winkler, I. Wittmann, G. Jermendy, Cardiovascular risk factors characteristic for the metabolic syndrome in adult patients with type 1 diabetes. Exp. Clin. Endocrinol. Diabetes 117, 107–112 (2009)PubMedCrossRef
Metadata
Title
Epicardial adipose tissue thickness in type 1 diabetic patients
Authors
Dilek Yazıcı
Beste Özben
Dilek Yavuz
Oğuzhan Deyneli
Hasan Aydın
Özlem Tarcin
Sema Akalın
Publication date
01-10-2011
Publisher
Springer US
Published in
Endocrine / Issue 2/2011
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9478-x

Other articles of this Issue 2/2011

Endocrine 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.